# Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

> **NCT05204329** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Illinois at Chicago** · enrollment: 9 (actual)

## Conditions studied

- Mesenchymal Stromal Cells
- Cornea
- Corneal Defect
- Corneal Epithelium Defect

## Interventions

- **BIOLOGICAL:** MSC Secretome Eye Drops

## Key facts

- **NCT ID:** NCT05204329
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-24
- **Primary completion:** 2024-11-08
- **Final completion:** 2024-11-08
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2026-01-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05204329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05204329, "Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05204329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*